Fig. 3From: Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney diseaseAssociation between baseline SST and annual change in mGFR (panel a) or annual change in htTKV (panel b) in patients with ADPKD receiving standard care. Standardized beta’s and p-values were calculated by linear regression analysisBack to article page